(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

GENEGLOBE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

GENEGLOBE

ST13

US500000078722164

Classe

1, 5, 9, 42

Pedido

78722164

Registro

3297334

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

48

Atualização mais recente

03/05/2024

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 42

Data de depósito

28/09/2005

Data de registro

25/09/2007

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

15/11/2017

Última transação

03/05/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

800

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

03

Localização do titular

Hilden, DE

Examinador

THOMAS JR, RAY

Unidade examinadora

L20

Localização atual

GENERIC WEB UPDATE

Titulares e representantes

Titulares

QIAGEN GmbH
QIAGEN GmbH

Representantes

Victoria Friedman Dennemeyer & Associates, LLC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Diagnostic preparationsexcept for human medicine and veterinary medicine purposes; reagents and solvents not for human medical and veterinary purposesin particular for sample preparationmodification and manipulation of cells as well as for the performance of labelingseparationisolationreproduction and purification methods for biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances; kits consisting primarily of siRNA compoundsprotein assays and chemical reagentsin particular for sample preparationmodification and manipulation of cells as well as for labelingseparationisolationreproduction and purification of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids and proteins from biological material

Classe 5

Products for human medicine and veterinary medicine purposesin particular diagnostic preparationsin particular for sample preparationmodification and manipulation of cells as well as for labelingseparationisolationreproduction and purification of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances; chemical biochemical and biotechnological products all for human medicine and veterinary medicine purposesin particular reagents and solventsin particular for sample preparationmodification and manipulation of cells as well as for the performance of labelingseparationisolationreproduction and purification methods for biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substances for diagnostic purposes; kits consisting primarily of siRNA compoundsprotein assays and chemical reagents for human medicine or veterinary medicine diagnostic purposesin particular for sample preparationmodification and manipulation of cells as well as for labelingseparationisolationreproduction and purification of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids and proteins from biological material

Classe 9

Scientific apparatusesinstruments and equipmentoptical apparatuses and instrumentscalculating machineselectrical and electronic apparatuses and instrumentsin particular for research and analysis purposeslaboratory equipmentmeasuring apparatuses and instrumentsrobot manipulatorslaboratory consumable dispenserslaboratory sample conditionersincubatorsstirrersmixersdispensersaspiratorslaboratory and measuring apparatuses and instrumentsfilter systems for laboratory purposesultrafiltration devices and apparatusesultrafiltration membraneschromatography apparatuses and instrumentsion exchanger apparatuses and instrumentslaboratory concentrator devicesscientific apparatuses and instruments being laboratory equipment and single-use laboratory articlesin particular laboratory apparatuses for the processing of fluid samplesin particular apparatuses for dosingtransferringmixingtemperingconcentratinghomogenizing and filtering of sample liquids and reagents for medical and veterinary medical diagnostic purposesin particular for sample preparationmodification and manipulation of cells and for labelingseparationisolationreproduction and the purification of biopolymersin particular nucleic acidsproteinsmacromolecules and biologically active substancesin particular nucleic acids and proteins from biological material

Classe 42

Scientific and technological servicesresearchdevelopment and diagnostics in the field of cancer treatment and diagnosistreatment and diagnosis of viral and bacterial mediated diseasestreatment and diagnosis of diseases of the bloodtreatment and diagnosis of diseases of the skintreatment and diagnosis of diseases of the braintreatment and diagnosis of diseases of the hearttreatment and diagnosis of diseases of the livertreatment and diagnosis of diseases of the lungs; as well as design serviceswork on and evaluation of chemical synthesesin particular the synthesis of oligonucleotidespolynucleotides and proteins

Publicações

Histórico de despachos e eventos da marca no USPTO.

48 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/05/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/05/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/05/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/05/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/05/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/05/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

21/07/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

21/07/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

21/07/2021

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

21/07/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

21/07/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

21/07/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

21/07/2021

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

15/11/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

15/11/2017

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

15/11/2017

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

07/11/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

25/10/2017

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

18/09/2017

XXXX

POST REGISTRATION ACTION CORRECTION

18/09/2017

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

04/09/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

04/09/2017

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

25/09/2016

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

29/10/2013

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

29/10/2013

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

21/10/2013

XXXX

POST REGISTRATION ACTION CORRECTION

21/10/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

28/09/2013

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

24/09/2013

E815

TEAS SECTION 8 & 15 RECEIVED

24/09/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

25/09/2007

PUBO

PUBLISHED FOR OPPOSITION

10/07/2007

NPUB

NOTICE OF PUBLICATION

20/06/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/06/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/06/2007

ACEC

AMENDMENT FROM APPLICANT ENTERED

07/06/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/06/2007

ALIE

ASSIGNED TO LIE

07/06/2007

MAIL

PAPER RECEIVED

21/05/2007

GNRT

NON-FINAL ACTION E-MAILED

18/11/2006

CNRT

NON-FINAL ACTION WRITTEN

18/11/2006

ACEC

AMENDMENT FROM APPLICANT ENTERED

26/10/2006

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/10/2006

MAIL

PAPER RECEIVED

12/10/2006

GNRT

NON-FINAL ACTION E-MAILED

10/04/2006

CNRT

NON-FINAL ACTION WRITTEN

10/04/2006

DOCK

ASSIGNED TO EXAMINER

31/03/2006

NWAP

NEW APPLICATION ENTERED

03/10/2005

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace GENEGLOBE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.